慢性疹第二部分:临床管理和治疗方法
Peyton V Warp1, Ana Maria Giménez-Arnau2, Brian S Kim3
1Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Journal of the American Academy of Dermatology
|January 6, 2026
概括
慢性疹 (CU) 是一个由巨细胞驱动的疾病,需要及时治疗以消除症状. 本综述涵盖抗组胺剂,免疫抑制剂,生物药物和用于有效治疗慢性疹的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 慢性疹 (CU) 是一种由巨细胞介导的疾病,导致持续超过六周的反复发和血管.
- 有效的CU管理对于疾病控制和改善患者生活质量至关重要.
研究的目的:
- 提供复杂的慢性疹管理的全面审查.
- 讨论CU目前和新兴的治疗策略.
主要方法:
- 关于慢性疹治疗的当前文献的审查.
- 分析抗组胺剂,免疫抑制剂和生物制剂的作用.
- 探索新的治疗方法和正在进行的调查.
主要成果:
- 抗胰岛素,免疫抑制剂和生物药物是CU管理的关键组成部分.
- 对CU的治疗环境充满活力,正在研究新的药物.
- 专注于通过安全,有效和最小剂量的疗法实现症状消除.
结论:
- 慢性疹的最佳管理需要采用多方面的方法.
- 包括生物药物和小分子在内的不断发展的治疗选择,为难以治疗的CU提供了希望.
- 对杆细胞导向疗法的持续研究对于推进CU护理至关重要.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
192
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
192
Myocarditis III: Medical Management
168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Hypersensitivities
7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Nephrotic Syndrome III : Nursing Management
277
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
277
Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312


